About Bilastine

Therapeutic Category

Antihistaminic

Dose Form

Status

In Pipeline

Available Regulatory Filing

CAS No

202189-78-4

Pharmacopoeia

Mechanism of Action

Bilastine is a non-sedating antihistamine that selectively antagonizes peripheral H1 receptors. By blocking these receptors, it reduces the effects of histamine, effectively alleviating symptoms associated with allergic rhinitis and urticaria without causing significant sedation.

Indication

Indicated for the symptomatic relief of allergic rhinitis and chronic urticaria.